Literature DB >> 20548853

A Hydroxyurea-induced Leg Ulcer.

Seon-Wook Hwang1, Soon-Kwon Hong, Sang-Hyun Kim, Jong-Keun Seo, Deborah Lee, Ho-Suk Sung.   

Abstract

Hydroxyurea is a cytostatic agent that has recently become the drug of choice in the treatment of various myeloproliferative diseases. The cutaneous side effects of hydroxyurea include xerosis, hyperpigmentation, nail discoloration, and scaling. Leg ulcers have only rarely been reported in association with hydroxyurea treatment. A 75-year-old woman presented with leg ulcers, nail discoloration, and xerosis. The leg ulcers were refractory to conventional treatment. She had been taking oral hydroxyurea since being diagnosed with essential thrombocytosis in 2002. Hence, we suspected hydroxyurea-induced leg ulcers and discontinued her hydroxyurea treatment; the ulcers gradually healed thereafter. We present a rare case of hydroxyurea-induced leg ulcers in Korea.

Entities:  

Keywords:  Cutaneous side effects; Hydroxyurea; Leg ulcer

Year:  2009        PMID: 20548853      PMCID: PMC2883366          DOI: 10.5021/ad.2009.21.1.39

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  12 in total

1.  Successful healing of hydroxyurea-related leg ulcers with topical granulocyte-macrophage colony-stimulating factor.

Authors:  F Stagno; P Guglielmo; U Consoli; P Fiumara; M Russo; R Giustolisi
Journal:  Blood       Date:  1999-08-15       Impact factor: 22.113

2.  Treatment of polycythemia vera: the use of hydroxyurea and pipobroman in 292 patients under the age of 65 years.

Authors:  Y Najean; J D Rain
Journal:  Blood       Date:  1997-11-01       Impact factor: 22.113

Review 3.  Mechanism of action of hydroxyurea.

Authors:  J W Yarbro
Journal:  Semin Oncol       Date:  1992-06       Impact factor: 4.929

Review 4.  Leg ulcers in patients with myeloproliferative disorders: disease- or treatment-related?

Authors:  U Bader; M Banyai; R Böni; G Burg; J Hafner
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

5.  Leg ulcers and hydroxyurea: forty-one cases.

Authors:  M E Sirieix; C Debure; N Baudot; L Dubertret; M E Roux; P Morel; C Frances; S Loubeyres; C Beylot; D Lambert; P Humbert; O Gauthier; M Dandurand; B Guillot; L Vaillant; G Lorette; J M Bonnetblanc; C Lok; J P Denoeux
Journal:  Arch Dermatol       Date:  1999-07

6.  Leg ulcer in a patient associated with hydroxyurea therapy.

Authors:  Joachim Dissemond; Daniela Hoeft; Julia Knab; Tom Franckson; Knut Kroger; Manfred Goos
Journal:  Int J Dermatol       Date:  2006-02       Impact factor: 2.736

7.  Leg ulcers associated with long-term hydroxyurea therapy.

Authors:  G Weinlich; G Schuler; R Greil; H Kofler; P Fritsch
Journal:  J Am Acad Dermatol       Date:  1998-08       Impact factor: 11.527

8.  Leg ulcers and hydroxyurea: report of three cases with essential thrombocythemia.

Authors:  Zeynep Demirçay; Asuman Cömert; Cafer Adigüzel
Journal:  Int J Dermatol       Date:  2002-12       Impact factor: 2.736

9.  Hydroxyurea and lower leg ulcers.

Authors:  T V Nguyen; D J Margolis
Journal:  Cutis       Date:  1993-10

10.  Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.

Authors:  G P Rodgers; G J Dover; N Uyesaka; C T Noguchi; A N Schechter; A W Nienhuis
Journal:  N Engl J Med       Date:  1993-01-14       Impact factor: 91.245

View more
  4 in total

1.  Prevalence and Predictive Factors for Leg Ulcers in Sickle Cell Disease Patients in Saudi Arabia: A Cross-Sectional Observational Study.

Authors:  Feroze Kaliyadan; Ahmed Z Alkhars; Alreem A Albaqshi; Hajar M AlHajri; Norah K Albaqshi; Rawan M Aldihnayn; Zainab Y Almarzooq
Journal:  Cureus       Date:  2020-10-31

2.  Leg ulcer induced by hydroxycarbamide in sickle cell disease: What is the therapeutic impact?

Authors:  Esaie Soya; Caroline Makowski; Sophie Blaise
Journal:  Int Wound J       Date:  2019-03-27       Impact factor: 3.315

3.  A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis.

Authors:  Charles Antwi-Boasiako; Biree Andemariam; Raffaella Colombatti; Eugenia Vicky Asare; Crawford Strunk; Connie M Piccone; Deepa Manwani; Donna Boruchov; Fatimah Farooq; Rebekah Urbonya; Samuel Wilson; Gifty Dankwah Boatemaa; Silverio Perrotta; Laura Sainati; Angela Rivers; Sudha Rao; William Zempsky; Ivy Ekem; Fredericka Sey; Catherine Segbefia; Baba Inusa; Immacolata Tartaglione; Andrew D Campbell
Journal:  Ann Hematol       Date:  2020-05-06       Impact factor: 3.673

4.  Hydroxyurea Associated Cutaneous Lesions: A Case Report.

Authors:  Viktor Simeonovski; Hristina Breshkovska; Silvija Duma; Ivana Dohcheva-Karajovanov; Katerina Damevska; Suzana Nikolovska
Journal:  Open Access Maced J Med Sci       Date:  2018-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.